Congress should ratify the proposed USMCA and in particular support its provision requiring 10 years of data protection for biologic drugs. The result will be a more competitive U.S. biopharmaceutical industry, more high-paying American jobs and more incentives to produce new cures.
April 1, 2015
This report explores how populism has overtaken many tech policy debates and proposes a counter philosophy of tech progressivism to better guide discussions and debates around tech policy issues.
March 17, 2015
How Canada is killing innovation in its pharmaceutical industry.
March 16, 2015
Smart regulatory reform focused on sectors that compete internationally can boost U.S. economic competitiveness while maintaining, or even increasing, social benefits.
March 9, 2015
Strong intellectual property protection needs to be central to any agreement.
March 9, 2015
To ensure the Trans-Pacific Partnership (TPP) Agreement creates a framework in which life sciences innovation flourishes throughout the TPP region, it needs to include 12 years of data protection for novel biologic drugs.
February 26, 2015
International infringement of U.S. intellectual property continues to take a significant toll on the U.S. economy.
February 17, 2015
IP protection is essential to future medical innovation.
February 13, 2015
In the past few years the IP environment inside Ecuador has deteriorated quite significantly.
February 11, 2015
Advertisers are taking steps to prevent their ads from appearing alongside unlicensed content.
January 8, 2015
Policymakers should be wary of adverse side effects when promoting competition for short-term consumer welfare.